(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are Synchronoss Technologies, RiceBran Technologies, and Rigel Pharmaceuticals.

The three biggest losers today are Aspen Group, SigmaTron International, and Schmitt Industries.

Winners today

1. Synchronoss Technologies (SNCR) – 764.41%

Synchronoss Technologies, Inc. provides cloud, digital, messaging, and network management platforms, products, and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Its platforms, products, and solutions include cloud sync, backup, storage, device set up, content transfer, and content engagement for user generated content; multi-channel messaging peer-to-peer communications and application-to-person commerce solutions; customer journey and workflow design, development, orchestration, and experience management solutions; and telecom network infrastructure designing, procuring, managing, and optimizing solutions. In addition, the company offers software development and customization services. It markets and sells its services through direct sales force and strategic partners. Synchronoss Technologies, Inc. was incorporated in 2000 and is headquartered in Bridgewater, New Jersey.

NASDAQ ended the session with Synchronoss Technologies jumping 764.41% to $4.13 on Tuesday, after two consecutive sessions in a row of losses. NASDAQ rose 0.2% to $14,432.49, after two successive sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, Synchronoss Technologies has a trailing twelve months EPS of $-4.68.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -26.88%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 7.1%, now sitting on 234.7M for the twelve trailing months.

More news about Synchronoss Technologies.

2. RiceBran Technologies (RIBT) – 26.67%

RiceBran Technologies, together with its subsidiaries, operates as a specialty ingredient company. It focuses on producing, processing, and marketing of value-added healthy, natural, and nutrient dense products derived from rice and other small grains. The company converts raw rice bran into stabilized rice bran (SRB) and high value derivative products, including RiBalance, a complete rice bran nutritional package derived from further processing of SRB; RiSolubles, a nutritious carbohydrate and lipid rich fraction of RiBalance; RiFiber, a protein and fiber rich insoluble derivative of RiBalance; and ProRyza products, which includes derivatives composed of protein and protein/fiber blends. Its SRB and derivative products are nutritional and beneficial food products that contain a combination of oil, protein, carbohydrates, vitamins, minerals, fibers, and antioxidants that enhance the nutritional value of consumer products. The company's SRB products are also marketed as feed ingredients in the animal nutrition markets. It serves food and animal nutrition manufacturers, wholesalers, and retailers in the United States and internationally. The company was formerly known as NutraCea and changed its name to RiceBran Technologies in October 2012. RiceBran Technologies was founded in 2000 and is headquartered in Tomball, Texas.

NASDAQ ended the session with RiceBran Technologies rising 26.67% to $0.38 on Tuesday, after two successive sessions in a row of gains. NASDAQ rose 0.2% to $14,432.49, after two consecutive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, RiceBran Technologies has a trailing twelve months EPS of $-1.18.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -93.64%.

Moving Average

RiceBran Technologies’s value is way higher than its 50-day moving average of $0.30 and way under its 200-day moving average of $0.74.

Revenue Growth

Year-on-year quarterly revenue growth declined by 4.7%, now sitting on 41.16M for the twelve trailing months.

Sales Growth

RiceBran Technologies’s sales growth is 48.4% for the current quarter and 32% for the next.

Volume

Today’s last reported volume for RiceBran Technologies is 39675 which is 1.72% above its average volume of 39003.

More news about RiceBran Technologies.

3. Rigel Pharmaceuticals (RIGL) – 16.23%

Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is in phase III clinical trial for the treatment of warm autoimmune hemolytic anemia; phase III clinical trial for the treatment of hospitalized COVID-19 patients; and phase III clinical trial for the treatment of COVID-19. In addition, the company is developing R289, an oral interleukin receptor associated kinase 1/4 inhibitor, which is in phase I clinical trial for autoimmune, inflammatory, and hematology-oncology diseases; and R552, a receptor-interacting serine/threonine-protein kinase 1 inhibitor that has completed phase I clinical trial for autoimmune and inflammatory diseases. It has research and license agreements with AstraZeneca AB for the development and commercialization of R256, an inhaled JAK inhibitor; BerGenBio AS for the development and commercialization of AXL inhibitors in oncology; and Daiichi Sankyo to develop murine double minute 2 inhibitors for solid and hematological malignancies, as well as license and supply agreement with Kissei Pharmaceutical Co., Ltd. to develop and commercialize Fostamatinib. The company also has a license agreement and strategic collaboration with Eli Lilly and Company to co-develop and commercialize R552 for various indications, including autoimmune and inflammatory diseases, as well as other non-central nervous system (non-CNS) disease development candidates. Rigel Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in South San Francisco, California.

NASDAQ ended the session with Rigel Pharmaceuticals rising 16.23% to $1.32 on Tuesday while NASDAQ jumped 0.2% to $14,432.49.

Earnings Per Share

As for profitability, Rigel Pharmaceuticals has a trailing twelve months EPS of $-0.14.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Rigel Pharmaceuticals’s EBITDA is 1.73.

Revenue Growth

Year-on-year quarterly revenue growth grew by 41.3%, now sitting on 129.37M for the twelve trailing months.

Volume

Today’s last reported volume for Rigel Pharmaceuticals is 1751960 which is 47.12% above its average volume of 1190830.

More news about Rigel Pharmaceuticals.

4. Cigna (CI) – 16.01%

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.

NYSE ended the session with Cigna jumping 16.01% to $300.23 on Tuesday, after two successive sessions in a row of gains. NYSE jumped 0.37% to $16,268.06, after two consecutive sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, Cigna has a trailing twelve months EPS of $17.73.

PE Ratio

Cigna has a trailing twelve months price to earnings ratio of 16.93. Meaning, the purchaser of the share is investing $16.93 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.99%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Cigna’s EBITDA is 0.53.

Previous days news about Cigna

• Cigna ups stock buyback by $10 billion, will reportedly drop bid to buy humana. According to MarketWatch on Sunday, 10 December, "The potential Humana acquisition, first reported in late November, had sent Cigna shares about 10% lower, as investors were skeptical it could be successfully pulled off.", "In a statement, Cigna said it intends to use the majority of its discretionary cash flow for share repurchases next year, buying back at least $5 billion of its stock by the end of the first half of 2024."
• US stocks mixed; cigna shares spike higher. According to Business Insider on Monday, 11 December, "Shares of Cigna Group (NYSE:CI) traded higher on Monday after the company reportedly ended its attempt to negotiate an acquisition deal with rival Humana Inc (NYSE:HUM) after the pair disagreed on price terms."

More news about Cigna.

5. Cigna (CI) – 16.01%

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.

NYSE ended the session with Cigna rising 16.01% to $300.23 on Tuesday, after two sequential sessions in a row of gains. NYSE jumped 0.37% to $16,268.06, after two consecutive sessions in a row of gains, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, Cigna has a trailing twelve months EPS of $17.73.

PE Ratio

Cigna has a trailing twelve months price to earnings ratio of 16.93. Meaning, the purchaser of the share is investing $16.93 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.99%.

Previous days news about Cigna

• Cigna ups stock buyback by $10 billion, will reportedly drop bid to buy humana. According to MarketWatch on Sunday, 10 December, "We believe Cigna’s shares are significantly undervalued and repurchases represent a value-enhancing deployment of capital as we work to support high-quality care, improved affordability and better health outcomes," Cigna Chief ExecutiveDavid M. Cordani said in a statement.", "The potential Humana acquisition, first reported in late November, had sent Cigna shares about 10% lower, as investors were skeptical it could be successfully pulled off."
• US stocks mixed; cigna shares spike higher. According to Business Insider on Monday, 11 December, "Shares of Cigna Group (NYSE:CI) traded higher on Monday after the company reportedly ended its attempt to negotiate an acquisition deal with rival Humana Inc (NYSE:HUM) after the pair disagreed on price terms."

More news about Cigna.

6. TOP Ships (TOPS) – 8.04%

Top Ships Inc. owns and operates tanker vessels worldwide. The company's medium range tanker vessels transport crude oil, petroleum products, and bulk liquid chemicals. As of December 31, 2020, it had a fleet with a total capacity of 672,396 deadweight tonnes (dwt) consisting of four 50,000 dwt product/chemical tankers and three 157,000 dwt tankers. The company was formerly known as Top Tankers Inc. and changed its name to Top Ships Inc. in December 2007. Top Ships Inc. was founded in 2000 and is based in Maroussi, Greece.

NASDAQ ended the session with TOP Ships jumping 8.04% to $17.73 on Tuesday while NASDAQ jumped 0.2% to $14,432.49.

Earnings Per Share

As for profitability, TOP Ships has a trailing twelve months EPS of $38.64.

PE Ratio

TOP Ships has a trailing twelve months price to earnings ratio of 0.46. Meaning, the purchaser of the share is investing $0.46 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.56%.

Yearly Top and Bottom Value

TOP Ships’s stock is valued at $17.73 at 01:32 EST, way below its 52-week high of $25.80 and way above its 52-week low of $5.51.

Moving Average

TOP Ships’s worth is way above its 50-day moving average of $8.30 and way higher than its 200-day moving average of $8.76.

Revenue Growth

Year-on-year quarterly revenue growth grew by 5.9%, now sitting on 82.95M for the twelve trailing months.

More news about TOP Ships.

7. Broadcom (AVGO) – 7.7%

Broadcom Inc. designs, develops, and supplies various semiconductor devices with a focus on complex digital and mixed signal complementary metal oxide semiconductor based devices and analog III-V based products worldwide. The company operates in two segments, Semiconductor Solutions and Infrastructure Software. It provides set-top box system-on-chips (SoCs); cable, digital subscriber line, and passive optical networking central office/consumer premise equipment SoCs; wireless local area network access point SoCs; Ethernet switching and routing custom silicon solutions; embedded processors and controllers; serializer/deserializer application specific integrated circuits; optical and copper, and physical layer devices; and fiber optic components and RF semiconductor devices. The company also offers RF front end modules and filter; Wi-Fi, Bluetooth, and global positioning system/global navigation satellite system SoCs; custom touch controllers; custom touch controllers; inductive charging; attached small computer system interface, and redundant array of independent disks controllers and adapters; peripheral component interconnect express; fiber channel host bus adapters; read channel based SoCs; custom flash controllers; preamplifiers; optocouplers, industrial fiber optics, and motion control encoders and subsystems; light emitting diode, ethernet PHYs, switch ICs, and camera microcontrollers. Its products are used in various applications, including enterprise and data center networking, home connectivity, set-top boxes, broadband access, telecommunication equipment, smartphones and base stations, data center servers and storage systems, factory automation, power generation and alternative energy systems, and electronic displays. Broadcom Inc. was incorporated in 2018 and is headquartered in San Jose, California.

NASDAQ ended the session with Broadcom jumping 7.7% to $1,017.04 on Tuesday while NASDAQ jumped 0.2% to $14,432.49.

Earnings Per Share

As for profitability, Broadcom has a trailing twelve months EPS of $32.96.

PE Ratio

Broadcom has a trailing twelve months price to earnings ratio of 30.86. Meaning, the purchaser of the share is investing $30.86 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 60.31%.

Moving Average

Broadcom’s worth is way higher than its 50-day moving average of $898.27 and way higher than its 200-day moving average of $795.50.

More news about Broadcom.

8. Etsy (ETSY) – 7.01%

Etsy, Inc., together with its subsidiaries, operates two-sided online marketplaces that connect buyers and sellers in the United States, the United Kingdom, Germany, Canada, Australia, France, and India. Its primary marketplace is Etsy.com that connects artisans and entrepreneurs with various consumers. The company also offers Reverb, a musical instrument marketplace; Depop, a fashion resale marketplace; and Elo7, a Brazil-based marketplace for handmade and unique items. In addition, it offers various seller services, including Etsy Payments, a payment processing service; Etsy Ads, an advertising platform; and Shipping Labels, which allows sellers in the United States, Canada, the United Kingdom, Australia, and India to purchase discounted shipping labels. Further, the company provides various seller tools, including Shop Manager dashboard, a centralized hub for Etsy sellers includes ability to manage inventory, check order status, receive notifications about repeat customers, add photos, listing videos, and purchase and print shipping labels. Additionally, it offers educational resources comprising blog posts, video tutorials, Etsy Seller Handbook, Etsy.com online forums, and insights; Etsy Teams, a platform to build personal relationships with other Etsy sellers; and a Star Seller program. As of December 31, 2022, it connected a total of 7.5 million active sellers to 95.1 million active buyers. The company was formerly known as Indieco, Inc changed its name to Etsy, Inc. in June 2006. Etsy, Inc. was founded in 2005 and is headquartered in Brooklyn, New York.

NASDAQ ended the session with Etsy jumping 7.01% to $85.69 on Tuesday, following the last session’s upward trend. NASDAQ rose 0.2% to $14,432.49, after two consecutive sessions in a row of gains, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, Etsy has a trailing twelve months EPS of $2.47.

PE Ratio

Etsy has a trailing twelve months price to earnings ratio of 34.69. Meaning, the purchaser of the share is investing $34.69 for every dollar of annual earnings.

Sales Growth

Etsy’s sales growth is 1.8% for the current quarter and 2.4% for the next.

Revenue Growth

Year-on-year quarterly revenue growth grew by 7%, now sitting on 2.71B for the twelve trailing months.

More news about Etsy.

9. Rockwell Medical (RMTI) – 6.67%

Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, dialyzers, drugs, specialized component kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. The company's dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. It is also developing other therapeutic product candidates for the treatment of hospitalized patients with acute heart failure; and home infusion therapy that allows patients to receive intravenous medications at home. Its target customers include medium and small sized dialysis chains and independent dialysis centers. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

NASDAQ ended the session with Rockwell Medical rising 6.67% to $1.76 on Tuesday, following the last session’s upward trend. NASDAQ jumped 0.2% to $14,432.49, after two consecutive sessions in a row of gains, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Rockwell Medical has a trailing twelve months EPS of $-0.95.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -49.34%.

More news about Rockwell Medical.

10. STAAR Surgical Company (STAA) – 6.64%

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone intraocular lenses, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. STAAR Surgical Company markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, and Italy. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

NASDAQ ended the session with STAAR Surgical Company rising 6.64% to $33.40 on Tuesday while NASDAQ rose 0.2% to $14,432.49.

Earnings Per Share

As for profitability, STAAR Surgical Company has a trailing twelve months EPS of $0.38.

PE Ratio

STAAR Surgical Company has a trailing twelve months price to earnings ratio of 87.89. Meaning, the purchaser of the share is investing $87.89 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.57%.

Sales Growth

STAAR Surgical Company’s sales growth is 15.9% for the current quarter and 19.4% for the next.

Moving Average

STAAR Surgical Company’s value is under its 50-day moving average of $37.03 and way below its 200-day moving average of $50.54.

More news about STAAR Surgical Company.

Losers Today

1. Aspen Group (ASPU) – -20.98%

Aspen Group, Inc., an education technology company, provides online higher education services in the United States. The company offers baccalaureate, master's, and doctoral degree programs in nursing and health sciences, business and technology, arts and sciences, and education fields through Aspen University and United States University. As of April 30, 2022, it had 13,334 degree-seeking students enrolled. Aspen Group, Inc. was founded in 1987 and is based in New York, New York.

NASDAQ ended the session with Aspen Group sliding 20.98% to $0.14 on Tuesday while NASDAQ jumped 0.2% to $14,432.49.

Earnings Per Share

As for profitability, Aspen Group has a trailing twelve months EPS of $-0.38.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.26%.

Sales Growth

Aspen Group’s sales growth is negative 24% for the current quarter and negative 29.3% for the next.

Volatility

Aspen Group’s last week, last month’s, and last quarter’s current intraday variation average was 0.74%, 0.13%, and 7.15%.

Aspen Group’s highest amplitude of average volatility was 6.87% (last week), 6.16% (last month), and 7.15% (last quarter).

Volume

Today’s last reported volume for Aspen Group is 29034 which is 6.02% above its average volume of 27385.

Moving Average

Aspen Group’s worth is way under its 50-day moving average of $0.16 and under its 200-day moving average of $0.14.

More news about Aspen Group.

2. SigmaTron International (SGMA) – -16.78%

SigmaTron International, Inc. operates as an independent provider of electronic manufacturing services (EMS). Its EMS services include printed circuit board assemblies and completely assembled (box-build) electronic products. The company also offers automatic and manual assembly and testing of products; material sourcing and procurement services; manufacturing and test engineering support services; design services; warehousing and distribution services; and assistance in obtaining product approval from governmental and other regulatory bodies. In addition, the company offers electronic and electromechanical manufacturing solutions. It primarily serves industrial electronics, consumer electronics, and medical/life sciences industries in the United States, Mexico, China, Vietnam, and Taiwan. The company markets its services through independent manufacturers' representative organizations. SigmaTron International, Inc. was incorporated in 1993 and is headquartered in Elk Grove Village, Illinois.

NASDAQ ended the session with SigmaTron International sliding 16.78% to $3.05 on Tuesday while NASDAQ rose 0.2% to $14,432.49.

Earnings Per Share

As for profitability, SigmaTron International has a trailing twelve months EPS of $1.86.

PE Ratio

SigmaTron International has a trailing twelve months price to earnings ratio of 1.64. Meaning, the purchaser of the share is investing $1.64 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.34%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 9.2%, now sitting on 397.85M for the twelve trailing months.

Moving Average

SigmaTron International’s value is under its 50-day moving average of $3.15 and way under its 200-day moving average of $3.73.

Earnings Before Interest, Taxes, Depreciation, and Amortization

SigmaTron International’s EBITDA is 50.04.

More news about SigmaTron International.

3. Schmitt Industries (SMIT) – -16.33%

Schmitt Industries, Inc., together with its subsidiaries, designs, manufactures, and sells test and measurement products worldwide. The company's Balancer segment offers computer-controlled vibration detection, balancing, and process control systems. Its products comprise SB-5500, an optional acoustic emission monitoring system (AEMS) control card to monitor the AE signals generated on the grinding machine; process control cards to provide enhanced control of the grinding process; SB-2000, a compact manual balancing system; and AE-1000, an AE control platform, which reduces air machine grinding time under the Schmitt Dynamic Balance System brand name. This segment sells its products to end user operators, as well as manufacturers of grinding machines for automotive, industrial, aerospace, and medical industries through independent manufacturers' representatives and distributors. Its Measurement segment provides laser and confocal chromatic white light sensors for distance, measurement, and dimensional sizing products under the Acuity brand name for various application, including manufacturing, lumber production, steel casting, glass and paper production, medical imaging, crane control and micron-level part, and surface inspection; and ultrasonic measurement products that measure the levels of liquid tanks and transmit that data through satellite to a secure Website for display, as well as remote tank monitoring products under the Xact brand name. Schmitt Industries, Inc. was founded in 1984 and is based in Portland, Oregon.

NASDAQ ended the session with Schmitt Industries sliding 16.33% to $0.03 on Tuesday while NASDAQ rose 0.2% to $14,432.49.

Earnings Per Share

As for profitability, Schmitt Industries has a trailing twelve months EPS of $-0.97.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -169.56%.

Volume

Today’s last reported volume for Schmitt Industries is 737 which is 75.87% below its average volume of 3055.

More news about Schmitt Industries.

4. TOR Minerals International (TORM) – -15.53%

TOR Minerals International, Inc. produces and sells specialty mineral products in the United States, Europe, and Asia. The company offers alumina trihydrate and boehmite halogen-free flame retardant and smoke suppressant fillers for plastics, rubber, and specialty applications; and beige and gray colored titanium dioxide (TiO2) pigments for use in paints, coatings, plastics, paper, and various other products. It also provides white TiO2, a pigment to add whiteness and opacity to paints and coatings, plastics, and other materials; and engineered fillers for use in plastics, paints, coatings, catalysts, and industrial products. The company was founded in 1973 and is headquartered in Corpus Christi, Texas.

NASDAQ ended the session with TOR Minerals International dropping 15.53% to $1.85 on Tuesday, after five consecutive sessions in a row of losses. NASDAQ rose 0.2% to $14,432.49, after two sequential sessions in a row of gains, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, TOR Minerals International has a trailing twelve months EPS of $-0.54.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -3%.

Yearly Top and Bottom Value

TOR Minerals International’s stock is valued at $1.85 at 01:32 EST, way under its 52-week high of $2.80 and above its 52-week low of $1.74.

Volume

Today’s last reported volume for TOR Minerals International is 1000 which is 15.25% below its average volume of 1180.

Moving Average

TOR Minerals International’s worth is way below its 50-day moving average of $2.10 and way under its 200-day moving average of $2.27.

More news about TOR Minerals International.

5. Riot Blockchain (RIOT) – -11.78%

Riot Platforms, Inc., together with its subsidiaries, operates as a bitcoin mining company in North America. It operates through Bitcoin Mining, Data Center Hosting, and Engineering segments. The company also provides co-location services for institutional-scale bitcoin mining companies; and critical infrastructure and workforce for institutional-scale miners to deploy and operate their miners. In addition, it engages in the design and manufacturing of power distribution equipment and custom engineered electrical products; electricity distribution product design, manufacture, and installation services primarily focused on large-scale commercial and governmental customers, as well as a range of markets, including data center, power generation, utility, water, industrial, and alternative energy; operation of data centers; and maintenance/management of computing capacity. The company was formerly known as Riot Blockchain, Inc. Riot Platforms, Inc. was incorporated in 1998 and is based in Castle Rock, Colorado.

NASDAQ ended the session with Riot Blockchain dropping 11.78% to $13.97 on Tuesday while NASDAQ rose 0.2% to $14,432.49.

Earnings Per Share

As for profitability, Riot Blockchain has a trailing twelve months EPS of $-1.8.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.88%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Riot Blockchain’s stock is considered to be oversold (<=20).

Sales Growth

Riot Blockchain’s sales growth is 47.7% for the ongoing quarter and 38.6% for the next.

More news about Riot Blockchain.

6. Marathon (MARA) – -11.5%

Marathon Digital Holdings, Inc. operates as a digital asset technology company that mines digital assets with a focus on the blockchain ecosystem and the generation of digital assets in United States. The company was formerly known as Marathon Patent Group, Inc. and changed its name to Marathon Digital Holdings, Inc. in February 2021. Marathon Digital Holdings, Inc. was incorporated in 2010 and is headquartered in Fort Lauderdale, Florida.

NASDAQ ended the session with Marathon falling 11.5% to $14.85 on Tuesday while NASDAQ rose 0.2% to $14,432.49.

Earnings Per Share

As for profitability, Marathon has a trailing twelve months EPS of $-3.08.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -42.13%.

Volume

Today’s last reported volume for Marathon is 34351500 which is 9.8% below its average volume of 38083800.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Marathon’s EBITDA is 12.64.

More news about Marathon.

7. Trinity Biotech plc (TRIB) – -9.09%

Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the United States, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease; sexually transmitted diseases consisting syphilis and herpes; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes. It also develops, manufactures, and distributes products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, lactate, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. In addition, the company sells raw materials to the life sciences industry and research institutes. The company sells its products through its direct sales force; and a network of independent distributors and strategic partners. Its customers include public health facilities, hospitals, and other outreach facilities, as well as clinical and reference laboratories. Trinity Biotech plc was founded in 1992 and is headquartered in Bray, Ireland.

NASDAQ ended the session with Trinity Biotech plc sliding 9.09% to $0.50 on Tuesday while NASDAQ jumped 0.2% to $14,432.49.

Earnings Per Share

As for profitability, Trinity Biotech plc has a trailing twelve months EPS of $-1.05.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1913.45%.

More news about Trinity Biotech plc.

8. Technical Communications Corporation (TCCO) – -8.58%

Technical Communications Corporation engages in the design, development, manufacture, distribution, marketing, and sale of communications security devices, systems, and services worldwide. The company primarily provides data, video, fax, and voice networks. Its products include government systems, such as CSD 3324 SE secure telephone, fax and data system; CSD 3324 SP telephone and fax system; DSD 72A-SP military bulk ciphering system; and DSP 9000 radio encryption system, as well as the HSE 6000 squad radio headset and telephone encryptor for public safety special operations, land mobile radio applications, and for military applications. The company also provides network security systems comprising network encryption systems with centralized key and device management for IP, SONET/SDH, and frame relay networks to secure data in transit from local area network to local area network and across wide area networks. In addition, it offers secure office systems, such as CSD 4100 executive secure telephone and CipherTalk 8500 Internet protocol (IP)-based secure wireless phone. The company's products are used to protect confidentiality in communications between radios, landline telephones, mobile phones, facsimile machines, data network equipment over wires, fiber optic cables, radio waves, and microwave and satellite links. Further, it offers funded research and development, and technology development services. The company serves various markets, including foreign and domestic governmental agencies, law enforcement and military agencies, telecommunications carriers, financial institutions, and multinational companies requiring protection of mission-critical information. It sells directly to customers, original equipment manufacturers, and value-added resellers using its in-house sales force, as well as domestic and international representatives, consultants, and distributors. Technical Communications Corporation was founded in 1961 and is based in Concord, Massachusetts.

NASDAQ ended the session with Technical Communications Corporation falling 8.58% to $0.28 on Tuesday, after five consecutive sessions in a row of losses. NASDAQ jumped 0.2% to $14,432.49, after two successive sessions in a row of gains, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, Technical Communications Corporation has a trailing twelve months EPS of $-1.24.

Moving Average

Technical Communications Corporation’s worth is way under its 50-day moving average of $0.58 and way below its 200-day moving average of $0.76.

Yearly Top and Bottom Value

Technical Communications Corporation’s stock is valued at $0.28 at 01:32 EST, way below its 52-week high of $1.10 and higher than its 52-week low of $0.28.

More news about Technical Communications Corporation.

9. Lumen Technologies (LUMN) – -8.05%

Lumen Technologies, Inc., a facilities-based technology and communications company, provides various integrated products and services under the Lumen, Quantum Fiber, and CenturyLink brands to business and residential customers in the United States and internationally. The company operates in two segments, Business and Mass Markets. It offers compute and application services, such as edge cloud services, IT solutions, unified communication and collaboration solutions, colocation and data center services, content delivery services, and managed security services; and IP and data services, including VPN data network, Ethernet, internet protocol (IP), and voice over internet protocol. The company also provides fiber infrastructure services comprising high bandwidth optical wavelength networks; and unlit optical fiber and related professional services. In addition, it offers voice and other services, including private line services, a direct circuit or channel specifically dedicated for connecting two or more organizational sites; a portfolio of traditional time division multiplexing voice services; and synchronous optical network-based ethernet, legacy data hosting services, and conferencing services. The company was formerly known as CenturyLink, Inc. and changed its name to Lumen Technologies, Inc. in September 2020. The company was incorporated in 1968 and is headquartered in Monroe, Louisiana.

NYSE ended the session with Lumen Technologies sliding 8.05% to $1.37 on Tuesday while NYSE rose 0.37% to $16,268.06.

Earnings Per Share

As for profitability, Lumen Technologies has a trailing twelve months EPS of $-11.49.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -153.72%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 17.1%, now sitting on 14.84B for the twelve trailing months.

More news about Lumen Technologies.

10. MicroVision (MVIS) – -7.42%

MicroVision, Inc. develops and sells lidar sensors used in automotive safety and autonomous driving applications. Its laser beam scanning technology is based on micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company also develops micro-display concepts and designs for head-mounted augmented reality (AR) headsets, as well as 1440i MEMS module supporting AR headsets; interactive display solutions for the smart speakers market; and Consumer Lidar used in smart home systems. In addition, it develops 1st Generation LRL module. The company sells its products primarily to original equipment manufacturers and original design manufacturers. MicroVision, Inc. was founded in 1993 and is headquartered in Redmond, Washington.

NASDAQ ended the session with MicroVision dropping 7.42% to $2.37 on Tuesday while NASDAQ jumped 0.2% to $14,432.49.

Earnings Per Share

As for profitability, MicroVision has a trailing twelve months EPS of $-0.43.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -83.29%.

More news about MicroVision.

Stay up to date with our winners and losers daily report